NCT05248919
Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan treatment Not Available enrolling_by_invitation NCT00001971
Evaluation of Patients With Liver Disease No drug interventions Not Available Not Available recruiting NCT03620474
Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis treatment 1 / 2 completed NCT04798521
TeleHepC Treatment Trial No drug interventions supportive_care Not Available completed NCT00004850
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection No drug interventions Not Available Not Available completed NCT01350648
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection No drug interventions Not Available Not Available completed NCT06606197
Hepatitis C Prevalence in Men Who Have Sex with Men No drug interventions Not Available Not Available completed NCT05413785
Hepatitis C Treatment in Probation and Parole Office No drug interventions health_services_research Not Available recruiting NCT05868005
Delivering a Multi-disease Screening Tool to Migrant Populations No drug interventions screening Not Available recruiting NCT06380166
Hepatitis C Lab Testing Comparison Study No drug interventions Not Available Not Available recruiting NCT06409169
DBS TaT in Peer-assisted Telemedicine for Hepatitis C No drug interventions treatment Not Available not_yet_recruiting NCT01215643
Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants treatment 2 completed NCT02116543
TD-6450 MAD Study in HCV Infected Subjects No drug interventions treatment 1 completed NCT00707603
Chronic Hepatitis C and Insulin Resistance No drug interventions Not Available Not Available completed NCT00078403
Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) treatment 2 completed NCT01644903
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients No drug interventions Not Available Not Available recruiting NCT03407703
Hepatitis C (HCV) Cure and Kidney Health Not Available Not Available unknown_status NCT02904603
Immune Monitoring of Hepatitis C Under DAA Therapy No drug interventions Not Available Not Available unknown_status NCT02795403
HCV Virions Bound Proteins No drug interventions basic_science Not Available completed NCT04320290
HCV + to HCV - Kidney Transplant No drug interventions prevention 4 withdrawn NCT04812990
A Cross Sectional Observational Study on Relation Between Oral Manifestation and Hepatitis C in Egypt No drug interventions Not Available Not Available completed NCT01482390
A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C treatment 2 completed NCT02597790
A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects No drug interventions Not Available Not Available completed NCT00560690
The Effect of Adding Metformin to the Treatment of Hepatitis C treatment 4 completed NCT04090164
Association of Hepatitis C Virus With Breast Cancer No drug interventions Not Available Not Available completed NCT00590564
SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study No drug interventions treatment 2 completed NCT00383864
Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation. treatment 4 completed NCT00915564
A Study to Investigate the Potential Pharmacokinetic Interaction Between TMC435 and Methadone treatment 1 completed NCT00983164
Blood Antioxidant Status in Chronic Hepatitis C Patients Before and After Antioxidant Supplementation: a Randomized Clinical Trial No drug interventions supportive_care Not Available completed NCT01959321
An Observational Study of Hepatitis C Virus in Pregnancy No drug interventions Not Available Not Available completed NCT01772121
Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India No drug interventions Not Available Not Available completed NCT04546802
HepATocellular Cancer Hcv Therapy Study treatment 3 withdrawn NCT00281502
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy treatment 2 unknown_status NCT04427202
Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC) No drug interventions health_services_research Not Available completed NCT00207402
Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin treatment 4 completed NCT03551002
Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego No drug interventions Not Available Not Available unknown_status NCT00444002
Oxidative Stress and Fatty Acids in Hepatitis C No drug interventions Not Available Not Available completed NCT02316184
Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons No drug interventions prevention Not Available completed NCT00420784
A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3) treatment 2 completed NCT00141284
An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C treatment 4 completed NCT00704184
Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007) treatment 2 completed NCT05498779
Ablation of Hepatocellular Carcinoma: a Nationwide Study No drug interventions Not Available Not Available completed NCT01290679
An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants treatment 3 completed NCT03214679
Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID) No drug interventions treatment Not Available completed NCT04600479
Study on the Prevalence of Hepatitis C In a psychiatRic Population No drug interventions other Not Available completed NCT02004379
Register of Telaprevir and Boceprevir in Routine Clinical Practice No drug interventions Not Available Not Available completed NCT02647879
Treatment as Prevention for Hepatitis C in Iceland No drug interventions Not Available Not Available recruiting NCT02116179
DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients No drug interventions prevention Not Available completed NCT04014179
Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs No drug interventions health_services_research Not Available recruiting NCT01756079
A Study to Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105) treatment 4 completed NCT02515279
An Observational Study of Peginterferon Alfa-2a Plus Ribavirin for Hepatitis C Virus (HCV) Infection in Austria Not Available Not Available completed NCT00241943
A Video-Based HCV Curriculum for Active Injection Drug Users No drug interventions Not Available Not Available completed NCT01423643
HCV/HIV Coinfection: Antiviral Therapy and Fibrosis No drug interventions Not Available Not Available completed NCT02094443
Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option treatment 2 completed NCT02474043
A Community-based, Behavioral Intervention to Improve Screening for Hepatitis C Among High-risk Young Adults in Wisconsin No drug interventions screening Not Available completed NCT03426787
Helping Empower Liver and Kidney Patients No drug interventions supportive_care Not Available completed NCT00752687
A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults Not Available 1 completed NCT04033887
Evaluation Study of RDTs Detecting Antibodies Against HCV No drug interventions Not Available Not Available completed NCT05127187
Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention Center No drug interventions Not Available Not Available completed NCT01889433
An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C treatment 3 completed NCT03809533
The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients treatment 2 active_not_recruiting NCT04525833
Liver Disease and Other Systemic Diseases No drug interventions Not Available Not Available unknown_status NCT03071133
Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy No drug interventions Not Available Not Available completed NCT00919633
Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C treatment 2 completed NCT04242433
HCV RAS Testing in Public Health Programs No drug interventions Not Available Not Available unknown_status NCT00403533
Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus treatment 2 completed NCT01458054
Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults treatment 1 completed NCT03235154
A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic treatment 4 completed NCT01315054
A Methadone Maintenance Treatment Outcome Study in Three Provinces in China No drug interventions health_services_research Not Available completed NCT00977054
Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral Load treatment 4 terminated NCT04499651
Testing of a Navigation Intervention for Hepatitis C and HIV No drug interventions health_services_research Not Available terminated NCT01842451
A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C treatment 2 completed NCT01253551
VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir No drug interventions treatment 1 completed NCT05472051
Health and Migration Trajectories of Housekeepers in Bamako No drug interventions Not Available Not Available completed NCT00724451
Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1) Not Available Not Available completed NCT00593151
Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C treatment 1 / 2 completed NCT00004851
Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies No drug interventions Not Available Not Available completed NCT01988753
Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases No drug interventions Not Available Not Available completed NCT02084953
Study to Determine the Effect of BMS-791325 on the ECG QTcF Interval in Healthy Subjects Not Available 1 completed NCT00381953
High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV treatment 3 completed NCT02652377
EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients No drug interventions treatment 1 completed NCT04437277
Screening for Chronic Hepatitis C Virus in Hospitalized Patients No drug interventions prevention Not Available completed NCT01091077
A Pilot Study of the Grapefruit Flavonoid Naringenin for HCV Infection No drug interventions treatment 1 completed NCT00051077
Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) treatment 2 withdrawn NCT01949077
Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir. No drug interventions Not Available Not Available withdrawn NCT00727077
Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED) Not Available Not Available terminated NCT00535847
A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy treatment 2 completed NCT03944447
Outcomes Mandate National Integration With Cannabis as Medicine treatment 2 recruiting NCT00879047
Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection Not Available 1 completed NCT02782247
Dynamic Liver Tests in Liver Disease No drug interventions Not Available Not Available completed NCT02347345
Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs treatment 4 completed NCT01033045
Epidemiological Study to Evaluate the Management of Patients With Chronic Hepatitis C and Previous Treatment Failure No drug interventions Not Available Not Available completed NCT00871845
Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients No drug interventions prevention Not Available terminated NCT01833845
Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and Hydroxychloroquine in Patients Infected With Hepatitis C treatment 1 / 2 terminated NCT04220645
Opportunstic Hepatitis C Virus Treatment No drug interventions health_services_research Not Available completed NCT02768545
Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2) treatment 4 unknown_status NCT01857245
Intensive Models of HCV Care for Injection Drug Users No drug interventions treatment Not Available completed NCT04891445
Hepatitis C in Severe Mental Disorders: Nursing Programme No drug interventions health_services_research Not Available unknown_status NCT00097045
Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C treatment 2 completed NCT03685045
ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings No drug interventions health_services_research Not Available recruiting NCT02395198
Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients No drug interventions Not Available Not Available unknown_status NCT01182298
Open Label Study to Evaluate Chronic Hepatitis C Treatment in Latino Subjects With and Without HIV Co-infection No drug interventions Not Available Not Available terminated NCT02833298
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening No drug interventions prevention Not Available completed NCT03883698
Safety of Sofosbuvir in People With Advanced Kidney Failure basic_science 3 completed NCT01192698
Intravenous Interferon During Liver Transplant No drug interventions treatment Not Available completed NCT03143998
Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4) treatment 4 withdrawn NCT01221298
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV) treatment 2 completed NCT02683005
Study of Hepatitis C Treatment During Pregnancy treatment 1 completed NCT02732405
Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis treatment 3 unknown_status NCT02404805
Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers other Not Available completed NCT01467505
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients treatment 2 terminated NCT05692505
Multicenter Performance Study of QuadQuik Invitro Diagnostic Device No drug interventions Not Available Not Available not_yet_recruiting NCT05208697
Tele-Harm Reduction No drug interventions treatment Not Available recruiting NCT01025297
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone treatment 1 / 2 unknown_status NCT03581383
Community Access, Retention in Care, and Engagement for Hepatitis C Treatment No drug interventions health_services_research Not Available completed NCT01081483
A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults treatment 1 completed NCT00562783
A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis No drug interventions treatment 2 completed NCT02768961
Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C) treatment 4 completed NCT02687061
Chronic Hepatitis B and C Recall Northern Holland No drug interventions Not Available Not Available unknown_status NCT03688061
Class II Invariant Chain HCV Vaccine Study No drug interventions prevention 1 completed NCT01292161
Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C treatment 2 completed NCT01534728
Identification of Hepatitis C Virus (HCV) Specific T Cells No drug interventions Not Available Not Available completed NCT03961828
Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus treatment 4 completed NCT01937728
Tailored Regimens of PEGASYS® and Ribavirin for Genotype 1 Chronic Hepatitis C Patients Trial (TARGET-1) treatment 4 completed NCT02772328
A Peer-based Mobile-health Intervention to Increase Access & Adherence to Hepatitis C Treatment & HIV Viral Suppression No drug interventions screening Not Available completed NCT01390428
Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Grazoprevir (MK-5172-013) treatment 1 completed NCT00709228
Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793) Not Available Not Available completed NCT04363411
Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral Infections No drug interventions prevention Not Available completed NCT03981211
Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs treatment Not Available recruiting NCT00538811
Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders treatment 2 / 3 completed NCT01795911
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin treatment 2 completed NCT01208311
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound No drug interventions Not Available Not Available completed NCT03513393
Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole. other 1 completed NCT01625793
Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health Outcomes basic_science Not Available withdrawn NCT01896193
Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection treatment 3 completed NCT05376371
Criminal Justice Coordinated Transitional Care No drug interventions supportive_care Not Available enrolling_by_invitation NCT02935478
Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation No drug interventions treatment Not Available suspended NCT02496078
A Phase 3 Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b Infection treatment 3 completed NCT02032888
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection. treatment 3 completed NCT03341988
Evaluation of Treatment of Chronic HCV Patients in Chronic Kidney Disease Versus End Stage Renal Disease Patients treatment 1 completed NCT03482388
Crowdsourcing to Promote HBV and HCV Testing in China No drug interventions screening Not Available completed NCT01343888
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1) treatment 3 completed NCT00973388
VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers No drug interventions treatment 1 completed NCT00295607
Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients prevention 2 completed NCT02070107
Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Hepatitis C Infection No drug interventions supportive_care Not Available withdrawn NCT04508907
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients treatment 4 recruiting NCT05369507
Eliminating HCV in Rural South Carolina Utilizing NP Led Mobile Clinics and Virtual Care Coordination No drug interventions treatment Not Available completed NCT01355107
Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease No drug interventions Not Available Not Available completed NCT02332707
Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011) treatment 2 completed NCT05146609
Acceptance of Hepatitis C Screening by Self-testing in High Risk and General Population No drug interventions screening Not Available recruiting NCT00007709
To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C, Along With Associated Risk Behaviors, in Patients With Severe Mental Illness (SMI). No drug interventions Not Available Not Available completed NCT04873609
Electronic Record Assimilation and Subsequent Eradication of Hepatitis C No drug interventions screening Not Available completed NCT05725109
Hepatitis C Diagnosis to Treatment Management No drug interventions Not Available Not Available completed NCT02625909
Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection. treatment 3 completed NCT00218556
Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1 No drug interventions prevention Not Available completed NCT04717856
Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA No drug interventions screening Not Available unknown_status NCT05103085
Screening for Hepatitis C Using a Rapid Diagnostic Orientation Test (TROD) in Patients Over 50 Years Old in the Digestive Endoscopy Department of the Europeen Hospital Marseille No drug interventions Not Available Not Available unknown_status NCT01231685
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection treatment 2 completed NCT01448915
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs) No drug interventions Not Available Not Available completed NCT03093415
Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care treatment 4 completed NCT00445315
A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients treatment 1 completed NCT00124215
Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection treatment 1 completed NCT00987337
Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects treatment 2 completed NCT03619837
Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant other 4 completed NCT00237432
Study of the Immune Response to Hepatitis C Virus No drug interventions Not Available Not Available completed NCT00315432
NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection treatment 2 completed NCT02647632
Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir treatment 2 completed NCT02159352
Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants Not Available 1 completed NCT02995252
The HOPE Study: Characterizing Patients With Hepatitis B and C Not Available Not Available recruiting NCT00015652
Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection treatment Not Available completed NCT02904252
The Prevalence and Severity of HCV Infection in Thalassemia Major and Thalassemia Intermedia in Siriraj Hospital No drug interventions Not Available Not Available completed NCT01329952
Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment No drug interventions Not Available Not Available unknown_status NCT01332552
A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects treatment 1 terminated NCT06306300
Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil) health_services_research 4 recruiting NCT03420300
EBR/GZR for HCV-1b Patients Receiving Hemodialysis treatment 4 completed NCT01921400
The Pathogenesis of Hepatitis C Virus Vertical Transmission No drug interventions Not Available Not Available completed NCT01537900
A Multiple Dose Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Participants (MK-5172-010) treatment 1 completed NCT02607800
Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy treatment 3 completed NCT02545400
Quantification of Side Effects During Hepatitis C Therapy No drug interventions Not Available Not Available completed NCT01888900
New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C No drug interventions treatment 2 completed NCT01430000
Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump No drug interventions treatment 1 / 2 withdrawn NCT02304159
Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics treatment 4 completed NCT01217359
Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling Not Available 1 completed NCT00117559
Improving Quality of Life for Veterans Undergoing Interferon Treatment No drug interventions treatment Not Available completed NCT04947475
Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community No drug interventions health_services_research Not Available active_not_recruiting NCT00810875
Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy No drug interventions Not Available Not Available terminated NCT06047275
HCV Microfluidic Diagnostics No drug interventions Not Available Not Available completed NCT03652675
Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV No drug interventions treatment Not Available completed NCT01619475
Adult-to-Adult Living Donor Transplant Cohort Study No drug interventions Not Available Not Available completed NCT03092375
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects treatment 3 completed NCT01425970
Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin treatment 2 terminated NCT01297270
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2) treatment 3 completed NCT02933970
Comparison of Telemedicine to Usual Care for HCV Management for Methadone-maintained Individuals No drug interventions health_services_research Not Available active_not_recruiting NCT02306070
Improving Fibrosis Outcomes With Metformin treatment 2 withdrawn NCT05904470
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV treatment 2 active_not_recruiting NCT01054742
Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2) Not Available Not Available completed NCT02562742
Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection Not Available Not Available completed NCT03706742
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention No drug interventions screening Not Available completed NCT04677842
European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric Protocol No drug interventions Not Available Not Available active_not_recruiting NCT00252642
Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C treatment Not Available completed NCT00736242
Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584) Not Available Not Available completed NCT01886599
Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease Not Available 1 completed NCT03627299
Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors treatment 4 completed NCT01419899
Increasing Viral Testing in the Emergency Department No drug interventions prevention 2 / 3 completed NCT02877199
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy No drug interventions Not Available Not Available completed NCT00251199
VX-950 and Peginterferon for Hepatitis C Not Available 1 completed NCT01275599
Drug-Drug Interaction Study Between Telaprevir and Buprenorphine treatment 1 completed NCT01878799
Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV treatment 2 completed NCT00110799
SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C treatment 2 completed NCT01592006
Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients treatment 4 terminated NCT01308606
TMC435-TiDP16-C116 - Relative Bioavailability and Food Effect Study treatment 1 completed NCT03935906
Reaching mEthadone Users Attending Community pHarmacies With HCV No drug interventions treatment Not Available completed NCT01010906
A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005) treatment 1 completed NCT02781649
Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients treatment 4 completed NCT01973049
UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis treatment 3 completed NCT02203149
Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058) treatment 2 / 3 completed NCT01473849
Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients No drug interventions Not Available Not Available unknown_status NCT01910636
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV Infection treatment 3 completed NCT01701336
Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients No drug interventions treatment 1 completed NCT00401336
Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging No drug interventions diagnostic Not Available completed NCT00494936
Effects of HIV and Hepatitis C Virus on the Brain No drug interventions Not Available Not Available completed NCT02699736
EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV No drug interventions Not Available Not Available enrolling_by_invitation NCT02294136
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection No drug interventions supportive_care Not Available completed NCT05713136
The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset No drug interventions Not Available Not Available recruiting NCT03186313
A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection treatment 3 completed NCT02405013
Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa treatment 2 completed NCT03992313
Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia No drug interventions screening Not Available unknown_status NCT03702218
Hepatitis C Positive Donor Into Hepatitis C Negative Recipients No drug interventions other 0 withdrawn NCT03483818
Pilot Trial of Directly Observed Anti HCV Therapy & Contingency Management in a Population on Opiate Substitute Therapy No drug interventions treatment Not Available completed NCT00023218
Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis treatment Not Available withdrawn NCT04653818
HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial other 4 completed NCT03205618
A Retrospective, Observational Study on the Effectiveness of Daclatasvir-Containing Regimens in Patients in KSA, UAE and Qatar No drug interventions Not Available Not Available completed NCT06492018
Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population No drug interventions diagnostic Not Available not_yet_recruiting NCT04982718
HCV Self-testing in Malaysia No drug interventions diagnostic Not Available unknown_status NCT04395118
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention for Elevated LFTs No drug interventions screening Not Available withdrawn NCT00466219
Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant treatment 3 completed NCT02053519
Can Vitamin D Supplementation Improve Hepatitis C Cure Rates treatment 3 completed NCT06357819
INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation No drug interventions Not Available Not Available completed NCT00055341
Treatment of Hepatitis C in Hemophilic Patients With HIV treatment 2 completed NCT02361541
Determination of HCV Prevalence in a HIV Patient Cohort in Phnom Penh, Cambodia No drug interventions Not Available Not Available completed NCT01962441
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection treatment 3 completed NCT03534141
Mild Hypothermia and Acute Kidney Injury in Liver Transplantation No drug interventions prevention Not Available terminated NCT02438917
Biomarkers of Liver Fibrosis No drug interventions Not Available Not Available terminated NCT04019717
Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection treatment 2 completed NCT00085917
Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients treatment 2 completed NCT02363517
The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach treatment 3 unknown_status NCT00001117
A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection No drug interventions Not Available Not Available completed NCT01727934
Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C treatment 2 unknown_status NCT04309734
Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects treatment 1 / 2 withdrawn NCT02705534
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1 treatment 3 completed NCT03402334
Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk Factors No drug interventions treatment Not Available completed NCT00720434
A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection treatment 2 completed NCT05465434
Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy. supportive_care 3 completed NCT04405024
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients No drug interventions diagnostic Not Available recruiting NCT00780416
Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C treatment 3 completed NCT00010816
Herbal Treatment of Hepatitis C in Methadone Maintained Patients No drug interventions treatment 2 completed NCT03537196
DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) treatment 4 completed NCT01143896
Hepatitis C Translating Initiatives for Depression Into Effective Solutions No drug interventions health_services_research Not Available completed NCT04036396
Prevention Support for People Leaving Jail No drug interventions prevention Not Available completed NCT02897596
Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients treatment 3 unknown_status NCT04575896
Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors treatment 4 completed NCT00621296
Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C treatment 2 completed NCT02786758
Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals No drug interventions Not Available Not Available completed NCT00917358
Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C treatment 4 completed NCT02895958
The Dublin Zepatier Study treatment 4 terminated NCT01718158
Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy treatment 3 completed NCT00277758
Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I treatment 1 terminated NCT03669835
The Sublimated Mare Milk Supplement in Hepatitis C No drug interventions treatment Not Available completed NCT00158535
Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection No drug interventions treatment 2 terminated NCT05270135
ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs No drug interventions prevention Not Available completed NCT02503735
Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD) treatment Not Available terminated NCT00001035
The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections treatment 1 completed NCT02607735
Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy treatment 3 completed NCT03090035
Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C Treatment treatment 3 completed NCT00097435
A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C treatment 2 completed NCT00911963
Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection treatment 1 / 2 completed NCT03566563
Epidemiology of Chronic Hepatitis C and Disease Modelling No drug interventions Not Available Not Available completed NCT00246363
A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C treatment 1 / 2 completed NCT00880763
A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016) treatment 2 completed NCT00008463
A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) treatment 2 completed NCT03014986
Current Treatment of HCV Infection After HSCT No drug interventions Not Available Not Available completed NCT02556086
A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1) treatment 2 withdrawn NCT01508286
Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects Not Available Not Available no_longer_available NCT03526939
DRug Use and Infections in Hai Phong ViEtnam Among Persons Who Inject Drugs No drug interventions Not Available Not Available completed NCT01654939
Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease prevention 4 withdrawn NCT02103439
An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients treatment 3 completed NCT03686722
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin other 1 completed NCT00158522
Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213) No drug interventions treatment 3 completed NCT03819322
The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients treatment 2 active_not_recruiting NCT01663922
Boceprevir and Ucalm (St John&Apos;s Wort) prevention 1 completed NCT00518622
Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED) treatment 1 completed NCT02139722
Patient-Centered Care and Asian Americans No drug interventions screening Not Available completed NCT01637922
Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone treatment 1 completed NCT03364725
Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study treatment 4 unknown_status NCT00343525
Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C treatment 1 completed NCT01280825
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing No drug interventions Not Available Not Available recruiting NCT00775125
VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state. treatment 1 completed NCT02215525
Treatment of Chronic HCV Infected Egyptian Patients With Electromagnetic Waves and Herbal Therapy No drug interventions treatment 3 unknown_status NCT06203925
Hepatitis C Virus Self-testing (HCVST) in Sexual and Gender Minorities in Rio de Janeiro No drug interventions Not Available Not Available not_yet_recruiting NCT00368225
Transplant-Related Accelerated Progression of Hepatitis C No drug interventions Not Available Not Available completed NCT03004625
Daclatasvir, Asunaprevir Plus Ribavirin for HCV Genotype 1b Without NS5A RAV treatment 3 completed NCT03740230
An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs No drug interventions Not Available Not Available completed NCT03231930
Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot Study No drug interventions diagnostic Not Available completed NCT02943330
Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life No drug interventions Not Available Not Available completed NCT01732848
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189) Not Available Not Available completed NCT00752648
TMC435350-TiDP16-C106: A Phase I Trial to Compare the Bioavailability and Plasma Pharmacokinetics After a Single Oral Dose of TMC435350 of 2 Different Solid Formulations Relative to a Powder Blend Capsule treatment 1 completed NCT00211848
Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers treatment 2 completed NCT02762448
Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas Not Available Not Available withdrawn NCT02936648
Hepatitis C Testing in VA Community-Based Outpatient Clinics No drug interventions diagnostic Not Available completed NCT00456248
Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin treatment 4 terminated NCT03109457
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma No drug interventions Not Available Not Available completed NCT01687257
Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation treatment 2 completed NCT01436357
Staged Phase I/II Hepatitis C Prophylactic Vaccine No drug interventions prevention 1 / 2 completed NCT00163657
Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection treatment 4 completed NCT03158857
Hepatitis C Treatment Study in Myanmar Not Available Not Available withdrawn NCT02961426
Strategic Transformation of the Market of HCV Treatments treatment 2 / 3 unknown_status NCT05181826
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer No drug interventions Not Available Not Available recruiting NCT03781726
Multi-center Study to Transplant Hepatitis-C Infected Kidneys prevention 4 completed NCT01492426
Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection treatment 3 completed NCT05467826
Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis treatment 4 unknown_status NCT00742326
Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections treatment 4 terminated NCT03433326
Grazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic Nephropathy Not Available Not Available unknown_status NCT02175966
Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study) treatment 2 completed NCT01858766
Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection treatment 2 completed NCT03111966
Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort No drug interventions Not Available Not Available completed NCT03032666
Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial treatment 4 completed NCT02669966
Live Kidney Donors With Positive Anti-HCV Antibody, But Negative HCV PCR No drug interventions treatment Not Available completed NCT02045966
Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects Not Available 1 completed NCT03654365
Advanced Electronic Population Health and Personal Health Record Tools to Improve Once Lifetime Hepatitis C Screening No drug interventions screening Not Available completed NCT04585165
User-friendly HIV Testing and Counseling Services No drug interventions Not Available Not Available recruiting NCT02393365
Prevalence and Screening of Hepatitis C in Belgium in 2015 No drug interventions diagnostic Not Available completed NCT06367465
Feasibility and Acceptability of HCV Treatment in Pregnancy Not Available Not Available recruiting NCT05067374
Hepatitis C Screening Paired With Mammography No drug interventions Not Available Not Available recruiting NCT00038974
Hepatitis C Antiviral Resistance in African-Americans treatment 3 completed NCT05368974
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry No drug interventions Not Available Not Available unknown_status NCT03025074
Blood Collection Biorepository for Liver Disease Research No drug interventions Not Available Not Available recruiting NCT01579474
Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial treatment 3 completed NCT00244374
A Randomized Trial of Vaccine Adherence in Young Injection Drug Users prevention Not Available completed NCT02120274
Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C treatment 4 terminated NCT02902120
HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant treatment 4 completed NCT02335320
Qualification of Point-of-Care Assays for Management of HCV Patients No drug interventions Not Available Not Available unknown_status NCT01200420
Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects treatment 2 completed NCT01681420
Improving Blood Safety and HIV Testing in Brazil No drug interventions prevention Not Available completed NCT00926120
The Effects of Mogroside Sweetener on Viral Load in TreatmenT Naive Genotype 1 (GT 1) Subjects CHC No drug interventions treatment 2 completed NCT02214420
SMV + SOF With/Without RBV for IFN-II Patients With CHC treatment 4 completed NCT03221582
Impact of Hepatitis C Therapy and Bone Health treatment 4 terminated NCT00001982
History of Hepatitis C in Volunteer Blood Donors No drug interventions Not Available Not Available completed NCT01025531
Cell Bound Complement Activation Proteins as Markers of Liver Injury No drug interventions Not Available Not Available withdrawn NCT00154531
Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI No drug interventions Not Available Not Available unknown_status NCT00469131
Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid treatment 3 completed NCT01667731
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults treatment 3 completed NCT03245931
Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1 No drug interventions Not Available Not Available completed NCT00148031
Improving Hepatitis C Treatment in Injection Drug Users treatment 4 completed NCT00730431
Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002) No drug interventions treatment 1 completed NCT02133131
Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074) treatment 2 completed NCT02601573
Elbasvir/Grazoprevir (EBR/GZR) and Sofosbuvir (SOF) With and Without Ribavirin (RBV) in Cirrhotic Subjects With Chronic Hepatitis C Virus (HCV) Genotype 3 (GT3) Infection (MK-5172-083) treatment 2 completed NCT02734173
Pilot HCV Direct Acting Antiviral Therapy and Metabolism prevention 4 completed NCT04550273
Leptin and Liver Enzymes Responses to Aerobic Training in Hepatitis c Patients No drug interventions treatment Not Available unknown_status NCT00040027
Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin treatment 3 completed NCT03603327
Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection No drug interventions treatment Not Available completed NCT00076427
Leukapheresis for Research on HCV-Coinfected Patients No drug interventions Not Available Not Available completed NCT00781976
Antiviral Activity of AZD7295 in HCV Carriers treatment 1 completed NCT03293576
A Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion Rates No drug interventions prevention Not Available completed NCT02601976
Evaluation of Unipeg® for Response and Ongoing Safety in Pakistani Population treatment 4 completed NCT03579576
Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar No drug interventions Not Available Not Available completed NCT00845676
Treatment of Acute Hepatitis C Virus in HIV Co-Infection treatment 4 completed NCT00393276
Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals prevention 1 completed NCT00437476
Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy treatment 3 unknown_status NCT00037076
Prevalence of Hepatitis C Virus Infection in HIV-Infected Children No drug interventions Not Available Not Available completed NCT00348660
Screening for Hepatitis C During Pregnancy at a Toronto Inner City Prenatal Clinic No drug interventions Not Available Not Available completed NCT00164060
Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection No drug interventions Not Available Not Available terminated NCT00249860
A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects treatment 3 completed NCT01846494
Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C) No drug interventions Not Available Not Available completed NCT03895294
Effect of Strategies for the Treatment of Chronic Hepatitis C in Colombia No drug interventions health_services_research Not Available unknown_status NCT03249194
Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients treatment 0 completed NCT00135694
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant treatment 2 completed NCT04853394
Tajik Migrant Health Education Study No drug interventions prevention Not Available completed NCT03524794
HepCare: The Effectiveness of Community Based Interventions With Peer Support to Improve Case Detection, Carry Out Pre-treatment Assessments and Assist Underserved Populations Through HCV Treatment No drug interventions Not Available Not Available unknown_status NCT01582594
A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody Detection No drug interventions Not Available Not Available terminated NCT01318694
Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants treatment 3 completed NCT04137094
Development and Pilot Testing of a PHCI for Emergency Department Patients Who Decline Rapid HIV/ HCV Screening No drug interventions other Not Available completed NCT02657694
Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods Not Available Not Available unknown_status NCT02392494
Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002) No drug interventions treatment 1 completed NCT03908294
Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents No drug interventions Not Available Not Available completed NCT01124591
Brief Intervention for Drug Misuse in the Emergency Department No drug interventions treatment 2 completed NCT01647191
Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China No drug interventions prevention Not Available completed NCT01485991
TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy treatment 3 completed NCT02150291
A Pilot Study to Assess the Efficacy and Safety of Folic Acid and/or Vitamin B Complex on Hepatitis C Infected Patients Treated With Pegylated Interferon and Ribavirin. prevention 4 unknown_status NCT02881762
Maraviroc Efficacy for Hepatitis C treatment 4 completed NCT00125762
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy No drug interventions diagnostic Not Available completed NCT03707080
Direct Acting Antiviral-Post Authorization Safety Study No drug interventions Not Available Not Available completed NCT05668780
Buprenorphine Integration Research and Community Health No drug interventions health_services_research Not Available active_not_recruiting NCT01825980
Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients treatment 1 / 2 completed NCT00229580
Health Behavior Feedback Study for Veterans With Hepatitis C No drug interventions treatment 1 completed NCT01441180
GS-7977 With Ribavirin for Hepatitis C (SPARE) treatment 1 / 2 completed NCT04047680
eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs Not Available Not Available completed NCT00945880
Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Naive treatment 1 completed NCT01458080
WEUSKOP5410: Observational Study in ENABLE Clinical Trials Not Available Not Available completed NCT02596880
Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics treatment 3 completed NCT01336829
TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir. treatment 1 completed NCT01054729
Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients treatment 2 completed NCT01327729
Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C treatment 2 / 3 unknown_status NCT00828789
VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer treatment 1 completed NCT01565889
Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients. treatment 1 / 2 completed NCT02673489
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection treatment 3 completed NCT01740089
Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C treatment 2 / 3 completed NCT01467492
Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C treatment 4 terminated NCT01899092
Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C No drug interventions treatment 1 / 2 completed NCT00674492
Hepatitis C Virus (HCV) Treatment Completion or Withdrawal No drug interventions Not Available Not Available completed NCT01559844
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant treatment 2 completed NCT01323244
A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study treatment 3 completed NCT01448044
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C treatment 3 completed NCT03145844
Direct Acting Agents in Hepatitis C Patients No drug interventions Not Available Not Available completed NCT05042544
The National Australian HCV Point-of-Care Testing Program No drug interventions Not Available Not Available recruiting NCT03086044
Transplanting Hepatitis C Positive Organs treatment 4 recruiting NCT00638144
Prevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis C No drug interventions Not Available Not Available unknown_status NCT02772744
Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4 Not Available Not Available unknown_status NCT03208244
DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant No drug interventions prevention 4 terminated NCT03112044
Lung Transplant HCV, Pilot Study treatment 0 active_not_recruiting NCT03093740
Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant prevention 4 withdrawn NCT03456440
The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver Cirrhosis No drug interventions Not Available Not Available unknown_status NCT00188240
Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy treatment Not Available unknown_status NCT00527540
Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C treatment 3 completed NCT00446940
Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C treatment 2 completed NCT00947440
Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation Not Available 1 completed NCT01350167
Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease No drug interventions screening Not Available unknown_status NCT04026867
The DETECT HCV Linkage to Care Trial No drug interventions health_services_research Not Available active_not_recruiting NCT02455167
Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis other 3 terminated NCT00768001
Genetic Analysis of Liver Cancer No drug interventions Not Available Not Available terminated NCT00580801
An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection treatment 2 completed NCT00435201
Characterization of Clonal B Cell Populations in HCV Infection No drug interventions Not Available Not Available completed NCT04057001
Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study No drug interventions Not Available Not Available terminated NCT03980301
Screening Hepatitis Positive Women for Congenital Anomalies No drug interventions Not Available Not Available completed NCT00088504
Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C treatment 2 completed NCT00004804
Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C treatment 3 completed NCT01909804
Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection treatment 2 completed NCT01492504
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial Not Available Not Available completed NCT00856804
Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance treatment 2 unknown_status NCT01707472
Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis treatment 2 completed NCT02631772
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients treatment 4 completed NCT00707772
Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection treatment 4 completed NCT01838772
HCV Treatment in HIV Co-Infected Patients in Asia treatment 4 completed NCT01890772
Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1 treatment 2 / 3 withdrawn NCT01500772
Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C treatment 3 terminated NCT02590068
Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination basic_science Not Available terminated NCT00495768
Reducing Depressive Symptoms During HCV Therapy: A Randomized Study No drug interventions prevention Not Available unknown_status NCT00684268
Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders treatment 2 completed NCT01183169
Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment treatment 2 completed NCT01704846
Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine Capsules treatment 1 completed NCT04809246
Prisons Evaluation of a One-stop-shop InterVentiOn No drug interventions health_services_research Not Available completed NCT03627546
HCV Seek, Test and Rapid Treatment for Young PWID No drug interventions treatment Not Available completed NCT00926146
Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV No drug interventions prevention Not Available completed NCT00004846
Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV No drug interventions Not Available Not Available completed NCT00688012
Safety Study of SPC3649 in Healthy Men treatment 1 completed NCT02825212
Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia treatment 2 / 3 completed NCT02161510
Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Participants With Hepatitis C (MK-2248-002) No drug interventions treatment 1 completed NCT00333710
Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD No drug interventions Not Available Not Available completed NCT03447210
Study of HIV, HCV, APS and Phylogenetics for PWID No drug interventions diagnostic Not Available completed NCT01667081
Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017) Not Available Not Available completed NCT04540081
Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer No drug interventions prevention Not Available completed NCT01912495
Dutch Acute HCV in HIV Study (DAHHS) treatment 2 completed NCT03088995
Pilot Study of HIV and Hepatitis B and C Screening in Surgery No drug interventions Not Available Not Available completed NCT00930995
Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C treatment 2 withdrawn NCT03804814
Motivational Interviewing for HCV Elimination No drug interventions other Not Available terminated NCT00350714
BreathID Multi-center HCV Liver Breath Test Study No drug interventions diagnostic 2 terminated NCT03791814
A Prospective Cohort Study to Improve HCV Care in Dialysis Patients treatment 4 withdrawn NCT00926614
Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba treatment 4 completed NCT04885855
8- Versus 12-week of Sofosbuvir-ravidasvir Treatment of Chronic Hepatitis C treatment 2 / 3 unknown_status NCT03290755
Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux No drug interventions Not Available Not Available completed NCT03197155
Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence No drug interventions Not Available Not Available completed NCT01429155
Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B No drug interventions Not Available Not Available completed NCT03831555
Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic No drug interventions other Not Available completed NCT05248555
The National Australian HCV Point-of-Care Testing Program - Minimal Dataset No drug interventions Not Available Not Available recruiting NCT00612755
Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4 treatment 4 completed NCT04048850
Zepatier in Patients With Substance Use Not Available Not Available unknown_status NCT01285050
Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds basic_science 4 completed NCT00707850
Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection treatment 4 completed NCT03891550
Micro-elimination of Hepatitis C Virus Infection in Uremics treatment 3 unknown_status NCT02706223
Testing and Treating Hepatitis C in Community Pharmacies No drug interventions health_services_research Not Available completed NCT03026023
Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant prevention 4 withdrawn NCT01389323
BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C treatment 3 completed NCT02044523
Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound No drug interventions Not Available Not Available completed NCT00722423
An Integrated Care Model for Improving Hepatitis C Virus Patient Outcomes No drug interventions health_services_research Not Available completed NCT00951223
Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients Infected With Hep C Not Available Not Available withdrawn NCT03241823
Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs. No drug interventions Not Available Not Available unknown_status NCT03125408
Clinical Performance Evaluation of DxN HCV Assay No drug interventions Not Available Not Available terminated NCT01274208
Examining the Immune Response in Patients With Gaucher Disease and Hepatitis C No drug interventions Not Available Not Available unknown_status NCT01603108
Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant treatment 2 unknown_status NCT03818308
Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir treatment 2 completed NCT00422838
Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients. No drug interventions Not Available Not Available completed NCT04719338
Occult HCV Infection After DAAD Treatment in Haemodialysis Patients No drug interventions screening Not Available completed NCT04017338
Transplantation Using Hepatitis C Positive Donors, A Safety Trial treatment 3 recruiting NCT04971538
HCV Self-testing in Pakistan No drug interventions diagnostic Not Available unknown_status NCT04662138
Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse No drug interventions Not Available Not Available unknown_status NCT04162938
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum No drug interventions health_services_research Not Available recruiting NCT00633243
Effective Treatment of Hepatitis C in Substance Users No drug interventions health_services_research Not Available completed NCT00758043
A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response treatment 3 completed NCT00031343
The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin No drug interventions treatment 2 completed NCT04959643
Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital No drug interventions Not Available Not Available unknown_status NCT02505243
Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens No drug interventions Not Available Not Available completed NCT00596843
Chronic Hepatitis Intervention Project for Drug Users No drug interventions prevention 3 completed NCT02104843
Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin Not Available 1 completed NCT02856243
Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis No drug interventions Not Available Not Available unknown_status NCT01250743
A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis C No drug interventions treatment Not Available terminated NCT02613403
Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) treatment 2 terminated NCT00058903
Treatment of Cholestatic Pruritus With Sertraline treatment 2 completed NCT05361603
Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures No drug interventions Not Available Not Available recruiting NCT01180790
Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants treatment 2 completed NCT04525690
Improving Inpatient Screening for Hepatitis C No drug interventions health_services_research Not Available completed NCT01413490
Hepatitis C Rimantadine and Antiviral Combination Therapy Not Available Not Available completed NCT01466790
A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients treatment 2 completed NCT00925990
CTS-1027 in Interferon-Naive Hepatitis C Patients treatment 2 completed NCT02251990
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067) treatment 3 completed NCT01816490
THISTLE - The HIV-HCV Silibinin Trial treatment 2 completed NCT03949764
The Kentucky Viral Hepatitis Treatment Study treatment 4 active_not_recruiting NCT00724464
Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209) Not Available Not Available completed NCT01273064
Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders treatment 2 terminated NCT02749864
Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP) No drug interventions Not Available Not Available completed NCT00704964
Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413) Not Available Not Available completed NCT01051921
Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders treatment 2 completed NCT03254121
Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response No drug interventions Not Available Not Available completed NCT02275221
Immune Response in Patients With Hepatitis B and C Infection No drug interventions Not Available Not Available recruiting NCT06349902
Re-link HCV in Substance-Use Telemedicine Program No drug interventions Not Available Not Available recruiting NCT03973502
Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PD No drug interventions diagnostic Not Available unknown_status NCT02755402
Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs No drug interventions health_services_research Not Available completed NCT01585584
Triple-Therapy in Patients With HCV Genotype 3 Who Previously Failed Treatment treatment 3 completed NCT00437684
Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy treatment 3 unknown_status NCT01469884
Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients supportive_care 4 completed NCT03200184
Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients treatment 4 completed NCT02992184
PoC-HCV Genedrive Viral Detection Assay Validation Study No drug interventions Not Available Not Available completed NCT02574884
Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope Glycoproteins No drug interventions prevention Not Available completed NCT01317784
Behavioral Science Aspects of Rapid Test Acceptance No drug interventions screening Not Available completed NCT02959684
Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France No drug interventions Not Available Not Available unknown_status NCT00979979
Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test No drug interventions Not Available Not Available completed NCT01715779
Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies Not Available Not Available completed NCT00996879
Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy Subjects Not Available 1 completed NCT00371579
Rosuvastatin for Hepatitis C treatment Not Available withdrawn NCT01293279
HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China No drug interventions Not Available Not Available completed NCT01467479
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV) treatment 3 terminated NCT01272479
Prohepcidin, Inflammation and Iron Homeostasis in Hemodialysis Patients With Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT04618679
Application of 18F-FDOPA PET in Research of the Association Between HCV Infection and Parkinson's Disease. No drug interventions Not Available Not Available unknown_status NCT03625687
Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant prevention 4 terminated NCT00821587
Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation treatment 4 completed NCT00367887
A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects treatment 2 completed NCT03318887
Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNA No drug interventions Not Available Not Available completed NCT01790633
Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests No drug interventions screening Not Available completed NCT03212833
Impact of Insulin Resistance on Therapeutic Response for Oral Treatment of Chronic Hepatitis C Virus Infection No drug interventions Not Available Not Available unknown_status NCT03324633
Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV No drug interventions Not Available Not Available completed NCT02727933
Postmarketing Surveillance of the Safety and Effectiveness of Daclatasvir and Asunaprevir for the Treatment of Chronic HCV Genotype 1B Infection in the Routine Clinical Practice in Korea No drug interventions Not Available Not Available completed NCT00096733
Adult-to-Adult Living Donor Liver Transplantation Study No drug interventions Not Available Not Available completed NCT01433133
Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients No drug interventions treatment 1 / 2 terminated NCT00239733
Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection treatment 4 terminated NCT04003454
The DETECT HCV Screening Trial No drug interventions screening Not Available active_not_recruiting NCT01594554
A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China. No drug interventions Not Available Not Available unknown_status NCT01472354
Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults No drug interventions supportive_care Not Available completed NCT00314054
Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults treatment 1 completed NCT00724854
Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427) Not Available Not Available completed NCT01289951
Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis treatment 1 completed NCT02102451
Control and Elimination Within Australia of Hepatitis C From People Living With HIV No drug interventions Not Available Not Available unknown_status NCT01470651
Armodafinil for Patients Starting Hepatitis C Virus Treatment treatment 4 terminated NCT03670251
Evaluation of Hepatitis C Viral Load Quantification on DBS in Vietnam No drug interventions diagnostic Not Available completed NCT04061551
Eliminate Hepatitis C/EC Partnership Evaluation Protocol No drug interventions health_services_research Not Available unknown_status NCT00983853
Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV treatment 2 completed NCT03712553
Behavioral Science and Hepatitis C Screening Outreach No drug interventions screening Not Available completed NCT00866853
TMC435-TiDP16-C107: This Study Measures the (Possible) Influence of TMC435 on the Activity of a Selected Set of Drug-degrading Proteins by Measuring the Blood Levels of Drugs That Have Been Taken Together With TMC435 and That Are Known to be Specifically Degraded by These Drug-degrading Proteins. treatment 1 completed NCT00825877
Long-term Follow-up of HALT-C Sustained Virological Responders No drug interventions Not Available Not Available completed NCT02591277
Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection Not Available Not Available completed NCT04204447
Hepatitis C-Video vs. Brochure Education Delivery No drug interventions prevention Not Available completed NCT05449847
Plasma MicroRNA for Prediction of Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT00500747
Chiron Corp HCV E1/E2 Vaccine No drug interventions prevention 1 completed NCT04159545
Future Destinations: Journeys Towards Citizenship No drug interventions Not Available Not Available completed NCT06179498
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs No drug interventions health_services_research Not Available recruiting NCT06373198
Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina. No drug interventions Not Available Not Available not_yet_recruiting NCT01431898
Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection treatment 1 completed NCT02194998
Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy treatment 2 terminated NCT03775798
Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV. No drug interventions Not Available Not Available unknown_status NCT03702998
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population No drug interventions Not Available Not Available completed NCT00135798
Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation treatment 2 completed NCT01499498
The Boceprevir and Sildenafil Pharmacokinetics Study treatment 1 completed NCT03813498
Hepatitis C Patient Management and Family Health Education No drug interventions other Not Available unknown_status NCT03195205
Identification to Elimination in HCV-Infected Individuals No drug interventions diagnostic 0 completed NCT01830205
Pharmacokinetic and Safety Study of Daclatasvir in Patients With Renal Impairment treatment 1 completed NCT01225705
Safety Study of Raltegravir in HIV/HCV Co-infected Patients treatment 4 withdrawn NCT00725205
Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690) Not Available Not Available completed NCT04515797
QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir treatment 4 completed NCT03401697
Eliminating Hepatitis C Virus No drug interventions Not Available Not Available completed NCT00657397
Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices prevention 3 completed NCT00892697
Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV) treatment 2 completed NCT01224197
TMC435 HPC1004 - Phase I Study Investigating the Pharmacokinetics of TMC435 in Healthy Chinese Volunteers treatment 1 completed NCT05184283
Utilization of MAsS in Patients Undergoing LT for HCC No drug interventions Not Available Not Available terminated NCT01890083
A Health Intervention to Prevent Depression Hepatitis C Patients No drug interventions prevention 2 / 3 terminated NCT03591783
Impact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Related Liver Disease No drug interventions Not Available Not Available unknown_status NCT02441283
A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530 other 2 / 3 completed NCT01137383
Pegaferon and Ribavirin for Hepatitis C treatment 3 completed NCT03252483
Integrating HIV and Hepatitis C Screening in an Urban Emergency Department No drug interventions screening Not Available completed NCT01405183
Association Between Hepatitis C Infection and Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT00372983
Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy No drug interventions treatment 1 completed NCT00262483
Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis C Not Available 2 completed NCT04244383
Expression of Inflammasomes in HCV Patients No drug interventions other 4 unknown_status NCT02551861
A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3 treatment 2 withdrawn NCT02528461
Macrophage Activation Markers During Sofosbuvir-based Treatment Regimes of Chronic Hepatitis C Not Available Not Available completed NCT00980161
Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis C No drug interventions Not Available Not Available unknown_status NCT00484328
Ribavirin, Its Dosing Regime treatment 4 completed NCT02646111
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With and Without Ribavirin in Protease-Inhibitors ("PI") Failures treatment 3 unknown_status NCT02087111
Telaprevir in Genotype 3 HCV treatment 4 completed NCT03823911
Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication basic_science 4 completed NCT01442311
Directly Observed Hepatitis C Treatment in Methadone Clinics No drug interventions treatment Not Available completed NCT00069511
12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy. No drug interventions treatment 2 unknown_status NCT00207311
Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus treatment 4 completed NCT01105611
Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users treatment 4 unknown_status NCT00857311
MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED) No drug interventions treatment 1 completed NCT01474811
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network No drug interventions Not Available Not Available completed NCT00564811
Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) No drug interventions treatment Not Available completed NCT00727311
Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED) Not Available Not Available completed NCT00724893
Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423) Not Available Not Available completed NCT02045693
Drug Interaction & Methadone & Buprenorphine Not Available 1 completed NCT00441493
Fluvastatin Versus Hepatitis C Virus treatment Not Available completed NCT00128271
Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection treatment 1 completed NCT00787371
Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED) treatment 2 completed NCT03200171
Effect of DAAs on Behavior of HCC in HCV Patients No drug interventions Not Available Not Available completed NCT03253471
A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection No drug interventions treatment 1 terminated NCT01226771
Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1 treatment 3 completed NCT03523871
A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret treatment 2 completed NCT00833378
Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects. treatment 1 completed NCT01492478
Psychobiological Characterization of Depression in Hepatitis C No drug interventions Not Available Not Available unknown_status NCT01045278
Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy treatment 4 completed NCT01909778
Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis treatment 1 completed NCT03377478
Expanding the Pool in Lung Transplantation treatment 1 completed NCT00512278
Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C treatment 2 completed NCT02565888
A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/Cobicistat other 1 completed NCT00502788
Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study) treatment 2 completed NCT02971488
The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID No drug interventions Not Available Not Available completed NCT02063607
The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients No drug interventions treatment 1 completed NCT00300807
Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection No drug interventions treatment 1 unknown_status NCT05002907
Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi) No drug interventions Not Available Not Available completed NCT01335607
A Open-label Study to Evaluate the Relative Bioavailability of Samatasvir (IDX184) and Food Effect in Healthy Male Participants (MK-2355-006) Not Available 1 completed NCT00029107
Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis treatment 2 completed NCT01070407
A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV) No drug interventions prevention 1 completed NCT03801707
Utilization of Hepatitis C Positive Kidneys in Negative Recipients treatment 2 / 3 completed NCT02532907
Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs No drug interventions Not Available Not Available completed NCT00705107
Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247) Not Available Not Available terminated NCT05016609
Same-visit Hepatitis C Testing and Treatment (The QuickStart Study) health_services_research 4 recruiting NCT03415009
Prevalence of IL28B Polymorphism in Hepatitis C Patients No drug interventions Not Available Not Available completed NCT02740556
Evaluation of HepCure Toolkit to Improve Harvoni Adherence No drug interventions supportive_care Not Available completed NCT01716156
A Study of Different Durations of Treatment With Grazoprevir (MK-5172) in Combination With Ribavirin in Participants With Chronic Hepatitis C (MK-5172-039) treatment 2 completed NCT02483156
Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Tablet Plus Ribavirin Tablet (Part A) Versus Single Dose (2 Tablets) of EHCV Containing Sofosbuvir, Ribavirin, and Natural Anti-hemolytic (B) in Egyptian Adults With Chronic Genotype 4 HCV Infection treatment 2 / 3 completed NCT00704756
An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN) Not Available Not Available withdrawn NCT00998985
A Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Male Participants (MK-5172-004) treatment 1 completed NCT01957085
Undiagnosed Hepatitis C Infection in an Urban Hospital No drug interventions Not Available Not Available completed NCT04493385
The Hepatitis C Transplant Collaborative No drug interventions Not Available Not Available recruiting NCT04701437
Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants No drug interventions treatment Not Available recruiting NCT02745132
Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC) No drug interventions Not Available 4 unknown_status NCT00723632
Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED) Not Available Not Available completed NCT00021632
Effects of Ribavirin on Zidovudine or Stavudine No drug interventions Not Available Not Available completed NCT01309932
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin treatment 2 completed NCT00407732
Overcoming Psychiatric Barriers to the Treatment of Hepatitis C No drug interventions Not Available Not Available completed NCT03061032
Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients treatment 3 unknown_status NCT00958152
Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects Not Available 1 completed NCT01134952
Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV) prevention 4 completed NCT00239252
Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C treatment 3 completed NCT01726400
In Hepatitis C Patients Treated With Interferon and Ribavirin, Does Hepcidin Contribute to Treatment Induced Anaemia Not Available Not Available completed NCT05769400
Awareness of Osteoporosis in Patients With Hepatitis C Infection No drug interventions Not Available Not Available not_yet_recruiting NCT00904059
Drug-Drug Interaction Study in Healthy Subjects Not Available 1 completed NCT00439959
Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults No drug interventions diagnostic 1 terminated NCT02269059
Safety and Pharmacokinetics of MK-7680 in Participants With Hepatitis C (MK-7680-003) No drug interventions treatment 1 completed NCT01165359
Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected Adults No drug interventions treatment 1 completed NCT00363259
Pegintron Induction Therapy in HCV Non-Responders treatment 3 completed NCT02032875
Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant treatment 3 completed NCT00205075
Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression No drug interventions Not Available Not Available completed NCT01157975
Study the Relationship Between Obesity and Hepatitis C Replication other 2 withdrawn NCT04596475
Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor prevention 1 / 2 completed NCT02204475
Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066) treatment 3 withdrawn NCT02555475
The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary Hospital No drug interventions treatment Not Available completed NCT02156570
DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) treatment 4 completed NCT00502970
Short Course of Interferon Treatment in Patients With HCV Infection treatment 4 completed NCT03876470
Conquering Hepatitis C Via Micro-Elimination in Southwest Virginia No drug interventions Not Available Not Available unknown_status NCT01773070
A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study other 3 completed NCT03126370
Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF) other 4 completed NCT00725842
Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed) Not Available Not Available terminated NCT03441542
Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial Hospital No drug interventions supportive_care Not Available terminated NCT00755742
Lifestyle Intervention Targetting Obesity and Insulin Resistance in Chronic Hepatitis C No drug interventions treatment Not Available completed NCT00328042
Hepatitis C Self-Management No drug interventions health_services_research Not Available completed NCT02044042
Vertical Transmission of Hepatitis C Virus No drug interventions Not Available Not Available unknown_status NCT02402699
Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan No drug interventions Not Available Not Available completed NCT02753699
Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients Not Available 3 completed NCT00502099
Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4 treatment 4 completed NCT00959699
A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4) treatment 2 completed NCT03303599
Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6 No drug interventions Not Available Not Available completed NCT00938899
TMC435350-TiDP16-C101 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated Dosing No drug interventions Not Available 1 completed NCT01580306
Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment treatment 1 completed NCT02022306
TD-6450 SAD and MAD in Healthy Subjects No drug interventions treatment 1 completed NCT00203606
Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C treatment 4 completed NCT00814606
A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C treatment 2 withdrawn NCT03236506
A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV Study treatment 2 completed NCT02064049
Surveillance and Treatment of Prisoners With Hepatitis C treatment 4 completed NCT00947349
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 201335 as Softgel Capsule in Naive Hepatitis C Virus (HCV) Patients treatment 2 completed NCT00229749
Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients treatment 1 / 2 terminated NCT01924949
Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Nosocomial Genotype 1 HCV Infection treatment 2 completed NCT00328549
A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV) treatment 2 completed NCT03898349
eHealth Partnered Evaluation Initiative - Evaluation of the Initial Deployment of VA's Annie Texting System No drug interventions health_services_research Not Available completed NCT02970136
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention No drug interventions screening Not Available completed NCT03057236
Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy Patients No drug interventions treatment Not Available completed NCT00767936
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma No drug interventions Not Available Not Available terminated NCT00728936
Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients treatment 1 completed NCT03418636
The Staying Safe Intervention No drug interventions prevention Not Available unknown_status NCT00310336
Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine treatment 2 / 3 completed NCT03316313
Hepatitis C Screening in the Primary Care Setting No drug interventions Not Available Not Available completed NCT03939013
Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar) No drug interventions diagnostic Not Available completed NCT01329913
Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003) treatment 1 completed NCT00209118
Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C prevention Not Available completed NCT04191018
GastrOesophageal Varices After Sustained Virological Response No drug interventions Not Available Not Available unknown_status NCT00241618
Timing and Duration of Acute Hepatitis C Treatment treatment 4 completed NCT00266318
Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy treatment 4 completed NCT02890719
Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients. treatment 3 withdrawn NCT02278419
An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus Infection treatment 2 completed NCT03817619
Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole Tablet treatment 1 completed NCT00165919
Immune Response to Hepatitis C Virus No drug interventions Not Available Not Available withdrawn NCT06533319
Hepatitis C Treatment in Idaho County Jails treatment Not Available not_yet_recruiting NCT04710641
Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone treatment 2 active_not_recruiting NCT01415141
Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism treatment 4 withdrawn NCT02526641
Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT00241917
A Video-Based HCV Curriculum for Drug Users No drug interventions Not Available Not Available completed NCT00704717
Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301) Not Available Not Available completed NCT00381017
Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371) treatment 3 withdrawn NCT00686517
Evaluation of Peginterferon Alfa-2b Monotherapy and Combination With Ribavirin in Participants With Acute Hepatitis C (P03552/MK-4031-137) treatment 3 completed NCT03855917
Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir treatment 4 recruiting NCT01306617
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection treatment 2 completed NCT00121017
A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects treatment 2 withdrawn NCT03226717
Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy No drug interventions Not Available Not Available unknown_status NCT03268317
Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs No drug interventions Not Available Not Available unknown_status NCT05412017
EPIC: Evaluation of Pharmacy-based Identification and Treatment of HCV No drug interventions screening Not Available completed NCT02533934
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant treatment 4 completed NCT02881034
Ribavirin Bioavailability After Telaprevir Exposure No drug interventions Not Available Not Available completed NCT01497834
A Phase 3 Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) Patients treatment 3 completed NCT02650024
Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes No drug interventions Not Available Not Available completed NCT01292824
Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients No drug interventions treatment 1 completed NCT06010524
A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX No drug interventions Not Available Not Available recruiting NCT00449124
TG4040 in Patients With Chronic HCV No drug interventions treatment 1 withdrawn NCT05390424
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot No drug interventions diagnostic Not Available unknown_status NCT00071916
Racial Difference in HCV/Host Interactions No drug interventions Not Available Not Available completed NCT01330316
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients treatment 3 completed NCT02252016
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065) treatment 3 completed NCT00996216
Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390 treatment 3 completed NCT06369116
Trial of Hepatitis C Self-Testing in the Hands of Untrained Lay Users No drug interventions screening Not Available active_not_recruiting NCT00598416
Psychoeducation for Hepatitis and Alcohol Behaviors No drug interventions supportive_care Not Available completed NCT00547716
Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C Infection No drug interventions treatment Not Available withdrawn NCT02098616
Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus treatment Not Available completed NCT01025596
Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1) treatment 1 / 2 completed NCT03413696
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients No drug interventions Not Available Not Available completed NCT01549496
A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers treatment 1 withdrawn NCT03247296
Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving Sofosbuvir and Daclatasvir Not Available Not Available unknown_status NCT02760758
A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects No drug interventions treatment 1 completed NCT00545558
Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV treatment 1 completed NCT03127358
Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs No drug interventions treatment Not Available completed NCT05264558
Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30% treatment 4 completed NCT01930058
Safety, Pharmacokinetics, and Pharmacodynamics of MK-8876 in Participants With Hepatitis C Infection (MK-8876-003) No drug interventions treatment 1 completed NCT02641158
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S. No drug interventions treatment Not Available completed NCT01387958
A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C Patients treatment 2 terminated NCT00059358
Zidovudine Levels in HIV Infected Patients Being Treated for HCV treatment 1 / 2 completed NCT00630058
A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C Not Available 1 completed NCT01567735
A Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Patients treatment 3 completed NCT03365635
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C treatment 4 completed NCT03099135
A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection No drug interventions other 3 terminated NCT05108935
Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP health_services_research Not Available completed NCT03697135
Ask a Friend to Take a Test for Hepatitis C Infection No drug interventions Not Available Not Available completed NCT03186235
T Regulatory Cells in Hepatitis c Infected Patients No drug interventions Not Available Not Available completed NCT01593735
A Multiple Dose Study to Evaluate the Safety and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1) treatment 1 completed NCT01582035
Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir treatment 1 completed NCT00207363
Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC treatment 4 completed NCT01701063
An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus treatment 1 / 2 terminated NCT00958763
Alcohol Use Reduction in Methadone Individuals With Hepatitis C Virus(HCV) No drug interventions prevention 2 completed NCT03038763
Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers No drug interventions Not Available Not Available completed NCT00108563
VISN 20: Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C Patients No drug interventions prevention 4 completed NCT02068963
Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing No drug interventions Not Available Not Available completed NCT01258686
Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy treatment 3 completed NCT05624086
Hepatic Enzymes, Psychological Measures, and Sexual Dysfunction Responses to Aerobic Exercise in Hepatitis-C Men No drug interventions treatment Not Available recruiting NCT03135886
Project I Test: Implementing HIV Testing in Opioid Treatment Programs No drug interventions health_services_research Not Available recruiting NCT02366286
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants No drug interventions Not Available Not Available completed NCT00248339
Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection treatment 3 completed NCT00747539
Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy Not Available Not Available completed NCT03564639
Examining Hepatitis C Reinfection Rates in Kenya No drug interventions Not Available Not Available completed NCT01979939
UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects treatment 3 completed NCT02108639
To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet Not Available 1 completed NCT04063839
HCV Treatment in a Low-threshold Clinic Not Available Not Available unknown_status NCT02336139
A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use treatment 2 completed NCT01281839
An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy treatment 3 completed NCT00993122
Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients treatment 4 completed NCT01840722
Brief Intervention for Rural Women at High Risk for HIV/HCV No drug interventions health_services_research Not Available completed NCT04625322
HCV Treatment Initiation During Acute Psychiatric Admission No drug interventions treatment 4 unknown_status NCT05839522
Australian Hepatitis and Risk Survey in Prisons No drug interventions Not Available Not Available recruiting NCT03208322
Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults No drug interventions Not Available Not Available withdrawn NCT02648022
Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment No drug interventions health_services_research Not Available completed NCT02472925
Way to Cure HCV Adherence No drug interventions other Not Available completed NCT02836925
Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection treatment 2 completed NCT01202825
TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients treatment 1 completed NCT02600325
Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV treatment 3 completed NCT01821625
Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C treatment 2 / 3 terminated NCT00980330
A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment treatment 2 completed NCT01707030
Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C No drug interventions treatment Not Available completed NCT00724230
Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED) Not Available Not Available completed NCT01808248
Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3 treatment 2 completed NCT01273948
Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infection treatment 1 / 2 completed NCT01797848
Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients treatment 3 withdrawn NCT00275548
Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C prevention 4 completed NCT03169348
The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia treatment Not Available unknown_status NCT03487848
Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection treatment 2 terminated NCT00005657
Genetics of Hepatitis C Virus Infection No drug interventions Not Available Not Available completed NCT02992457
Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection treatment 4 completed NCT01197157
Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients treatment 2 / 3 completed NCT01827657
Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects No drug interventions treatment 1 completed NCT00167557
Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment treatment 4 withdrawn NCT03219957
Study of AT-527 in Healthy and HCV-Infected Subjects treatment 1 completed NCT00627926
A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV) treatment 3 completed NCT01717326
A Study of the Combination Regimen Grazoprevir (MK-5172) and Elbasvir (MK-8742) ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035) treatment 2 completed NCT02661126
Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-030) No drug interventions treatment 1 completed NCT04620226
UHN Inpatient Hepatitis C & B Screening No drug interventions screening 4 recruiting NCT00655226
Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients No drug interventions treatment Not Available terminated NCT01146626
Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients? treatment Not Available unknown_status NCT00982826
Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072 Not Available 1 completed NCT01856426
Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects No drug interventions treatment 1 completed NCT03902366
HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function No drug interventions Not Available Not Available completed NCT02785666
Swiss HCVree Trial treatment 3 completed NCT04122066
the Pulmonary Safety of Antihepatitis C Treatment Not Available Not Available unknown_status NCT01995266
Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual treatment 3 completed NCT03362866
Epidemiology of Hepatitis B, C and Delta in Reunion Island No drug interventions Not Available Not Available unknown_status NCT01497366
Phase 3 Study of Sofosbuvir and Ribavirin treatment 3 completed NCT03402165
Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C treatment 4 unknown_status NCT01721265
3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals No drug interventions Not Available Not Available terminated NCT01349465
3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection No drug interventions other 3 completed NCT00916474
Virology Follow up Study in Subjects Previously Treated With Telaprevir Not Available Not Available completed NCT03118674
Harvoni Treatment Porphyria Cutanea Tarda treatment 2 completed NCT03537274
Efficacy of Polyethylene Glycol-Interferon Alfa-2B (PEG-Intron, SCH 54031) Compared to Interferon Alfa-2B in Participants With Chronic Hepatitis C (MK-4031-016) treatment 2 / 3 completed NCT00781274
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy treatment 3 completed NCT03181074
Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults No drug interventions Not Available Not Available completed NCT00249574
Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1 treatment Not Available completed NCT05372874
Treatment of Hepatitis c by Using Direct-acting Antiviral No drug interventions Not Available Not Available unknown_status NCT00527774
Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients No drug interventions Not Available Not Available completed NCT02580474
The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure treatment 4 completed NCT01682720
Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection treatment 3 completed NCT05710120
Hepatitis C Screening Alerts No drug interventions Not Available Not Available completed NCT00984620
Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3) treatment 2 completed NCT02332720
Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012) treatment 2 completed NCT01289782
An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Patients treatment 3 completed NCT00391482
Study to Reduce Intravenous Exposures (STRIVE) No drug interventions Not Available 2 / 3 completed NCT00812331
A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV) treatment 2 completed NCT03222531
Expanding the Pool in Orthotopic Heart Transplantation other 2 active_not_recruiting NCT05466331
Rural New England Health Study (Phase 2) No drug interventions treatment Not Available recruiting NCT02319031
Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis treatment 3 completed NCT03767231
ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing No drug interventions health_services_research Not Available not_yet_recruiting NCT00018031
Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients treatment 2 completed NCT04268173
Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3 No drug interventions health_services_research Not Available completed NCT04236973
Truenat™ HCV RNA Assay Evaluation No drug interventions diagnostic Not Available completed NCT02718573
Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood No drug interventions Not Available Not Available completed NCT01094873
Study of a Novel Therapeutic Vaccine for Hepatitis C Virus No drug interventions treatment 1 completed NCT03468673
International Validation of a Sexual Quality of Life Questionnaire Specific to HIV and Hepatitis C (PROQOL-SexLife) No drug interventions Not Available Not Available completed NCT00164073
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection No drug interventions Not Available Not Available unknown_status NCT00903773
VX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevir. treatment 1 completed NCT03208127
DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant No drug interventions prevention 4 terminated NCT03595527
Universal HIV Screening and Targeted HCV Screening in Emergency Department No drug interventions diagnostic Not Available completed NCT01497327
Open-Label Hepatic Impairment Study treatment 1 completed NCT00979927
SPC3649 Multiple Dose Study in Healthy Volunteers treatment 1 completed NCT00133276
Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment prevention 2 / 3 completed NCT00918476
Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol) Not Available 1 completed NCT00389376
Phase I Trial of Silymarin for Chronic Liver Diseases basic_science 1 completed NCT02573376
Antiviral Pharmacology and Adherence in Drug Users No drug interventions other Not Available completed NCT03362476
Computer-based Intervention for Alcohol-using HIV/HCV+ Women No drug interventions health_services_research Not Available completed NCT02869776
Integrating HCV and HIV Screening During the Era of HIV Antigen Testing No drug interventions diagnostic Not Available completed NCT00938860
Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C treatment 4 completed NCT02095860
Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325 No drug interventions Not Available 1 completed NCT04036760
Implementation and Evaluation of Care Coordination in Linkage to Care for Hepatitis C Following Release From New York City Jails No drug interventions Not Available Not Available completed NCT03776760
Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination Not Available Not Available unknown_status NCT00703560
Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients No drug interventions Not Available Not Available completed NCT00728494
Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671) Not Available Not Available completed NCT00933894
VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram treatment 1 completed NCT02122094
Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men (MSM) in Two Vietnamese Cities No drug interventions treatment Not Available completed NCT01269294
TMC435-TiDP16-C117: The Effect of TMC435 on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers treatment 1 completed NCT01024894
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy treatment 1 / 2 unknown_status NCT05813691
Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spontaneous Opportunistic Screening Initiative. No drug interventions Not Available Not Available not_yet_recruiting NCT00822991
Sonazoid Enhanced Liver Cancer Trial for Early Detection No drug interventions diagnostic Not Available unknown_status NCT02940691
Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs treatment 4 terminated NCT00794391
Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs) No drug interventions prevention Not Available completed NCT02628691
Monitoring Liver Disease Progression in Hepatitis C/HIV Co-infected Patients With No-to-moderate Fibrosis, in Phnom Penh, Cambodia No drug interventions Not Available Not Available terminated NCT02565862
A Drug-drug Interaction Study Between Daclatasvir and Metformin other 1 completed NCT00039962
Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin treatment 3 completed NCT00277862
Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4 treatment 4 completed NCT00056862
Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3 treatment 4 completed NCT01932762
Efficacy and Safety of Combination Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin (RBV) in Genotype 2 Hepatitis C Infection (MK-5172-047) treatment 2 completed NCT02485262
Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience Not Available Not Available unknown_status NCT03833362
Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study) treatment 3 completed NCT02261662
Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection treatment Not Available unknown_status NCT02802280
Endothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection. Response to DAA Agents. No drug interventions Not Available 4 unknown_status NCT01008280
Baclofen to Reduce Alcohol Use in Veterans With HCV treatment 4 completed NCT03166280
Hepatitis c and Vitamin D and Iron Status Not Available Not Available unknown_status NCT01447680
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing No drug interventions Not Available Not Available completed NCT00151580
Treatment of Recurrent Hepatitis C After Liver Transplantation diagnostic 3 completed NCT01517529
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations No drug interventions Not Available Not Available completed NCT02956629
Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041) treatment 2 terminated NCT04113629
Simplified Monitoring Myanmar SM2 Study No drug interventions diagnostic Not Available completed NCT06263829
HCV Tappt Adherence Study No drug interventions other Not Available not_yet_recruiting NCT04698629
Hepatitis C Pharmacy-based Strategy for Injectors No drug interventions Not Available Not Available completed NCT01646489
Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects treatment 1 completed NCT00324389
Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes treatment 2 completed NCT03320889
Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2 No drug interventions supportive_care Not Available completed NCT00381992
Risk Assessment of Long-Haul Truck Drivers No drug interventions Not Available Not Available completed NCT04366492
HBV/HCV/HIV in Belgian Prisons No drug interventions screening Not Available completed NCT01277692
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients. No drug interventions other 1 completed NCT06316492
A Study Done by a Demonstrator and Two Professors in Public Health and Community Medicine Department in Faculty of Medicine in Assiut and New Valley University to Assess Knowledge, Attitude ,and Practice of Rural Population in a Remote Governorate ( New Valley ) Towards Hepatitis B and C Viruses No drug interventions Not Available Not Available not_yet_recruiting NCT02358044
Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077) treatment 3 completed NCT01424540
Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805 No drug interventions treatment 1 completed NCT02824640
Patient-Centered Models of HCV Care for People Who Inject Drugs No drug interventions treatment Not Available completed NCT01567540
A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C Patients treatment 1 terminated NCT03144440
Real World Experience of Chronic Hepatitis C (CHC) Treatment in Israel No drug interventions Not Available Not Available completed NCT02568540
C Tracker, Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey Study No drug interventions Not Available Not Available terminated NCT00160940
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis No drug interventions Not Available Not Available unknown_status NCT01482767
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection treatment 3 completed NCT01038167
A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults basic_science 1 completed NCT02083367
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome No drug interventions Not Available Not Available completed NCT04948801
SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients Not Available Not Available unknown_status NCT00006301
Immune Response to Hepatitis C Virus No drug interventions Not Available Not Available completed NCT01718301
HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin treatment 3 completed NCT02032901
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV treatment 3 completed NCT00188201
Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication No drug interventions Not Available Not Available unknown_status NCT03254901
Detection of Hepatitis C Infection by Oraquick Test Among Health Care Workers No drug interventions Not Available Not Available unknown_status NCT03585101
A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk other 4 withdrawn NCT01052701
Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment other 1 completed NCT00635804
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002) No drug interventions treatment 1 completed NCT04652804
Supporting Treatment Outcomes Among PWID No drug interventions treatment Not Available active_not_recruiting NCT01970904
Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients treatment Not Available completed NCT06159504
Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania treatment 0 not_yet_recruiting NCT02605304
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF treatment 2 terminated NCT01181804
Comparison of Safety and Resulting Blood Level Profiles After Administration of a New Boceprevir Tablet Versus Its Current Capsule Formulation for Treatment of Chronic Hepatitis C (P06992)(COMPLETED) treatment 1 completed NCT00150904
Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP) No drug interventions Not Available Not Available completed NCT01427504
Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers Not Available Not Available completed NCT01426204
Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1) No drug interventions Not Available Not Available unknown_status NCT03444272
Effect of Direct-acting Antiviral Drugs on Erectile Function treatment 3 unknown_status NCT00701272
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation No drug interventions Not Available Not Available unknown_status NCT00164372
Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users No drug interventions prevention 2 / 3 completed NCT03623568
Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant prevention 4 withdrawn NCT01591668
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C treatment 1 completed NCT04389268
P300 in Early Cognitive Impairment in Hepatitis C Virus No drug interventions Not Available Not Available completed NCT00741169
TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing. treatment 1 completed NCT02531269
Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period No drug interventions Not Available Not Available completed NCT02103569
Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325 Not Available 1 completed NCT00703469
A Study of MDX-1106 to Treat Patients With Hepatitis C Infection treatment 1 completed NCT00192569
Australian Trial in Acute Hepatitis C treatment 4 completed NCT04510246
Link Hepatitis C Notifications to Treatment in Tasmania No drug interventions treatment Not Available unknown_status NCT00317746
Trial of Citalopram for the Prevention of Depression prevention 3 completed NCT03359746
Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant treatment 4 unknown_status NCT01058512
A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy No drug interventions treatment 2 completed NCT03492112
A TEst and Treat Intervention aMong Current People Who Inject Drugs With HCV Attending Needle and Syringe PrOgrams screening Not Available completed NCT00114712
The Ribavirin Pregnancy Registry No drug interventions Not Available Not Available terminated NCT03570112
Transmission of Chronic Hepatitis C in Pregnancy Not Available Not Available completed NCT00001712
Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan No drug interventions Not Available Not Available completed NCT02123212
Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C No drug interventions screening Not Available completed NCT03366610
Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based Regimens No drug interventions Not Available Not Available completed NCT00470210
Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens treatment 4 completed NCT00132210
Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients treatment 4 completed NCT03512210
Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection treatment 4 completed NCT01525810
Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial Not Available Not Available completed NCT00493610
Mucomyst for Hepatitis C treatment Not Available suspended NCT00946010
Investigation of Hepatitis B and Hepatitis C in Taiwan No drug interventions Not Available Not Available completed NCT03803410
Surveillance of HCV in Uremics and Linking to Medical Care No drug interventions Not Available Not Available completed NCT04411381
Telemedicine-based Model of Care for the Management of Hepatitis C Infected Patients No drug interventions health_services_research Not Available recruiting NCT00100581
Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults treatment Not Available completed NCT05582681
HCV Test and Treat Utilizing Simplified HCV Patient Education treatment 4 recruiting NCT01050881
Notification of Donors With Positive Microbiology Markers No drug interventions Not Available Not Available completed NCT00976781
Identifying the Gaps in the Diagnosis and Management of Hepatitis C No drug interventions Not Available Not Available withdrawn NCT05466981
HCV-Smoking Cessation Study No drug interventions treatment Not Available completed NCT01445795
Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve Subjects treatment 1 / 2 completed NCT00643695
Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C No drug interventions treatment Not Available completed NCT00724295
Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505) Not Available Not Available completed NCT03923595
Puglia HCV Micro-elimination Program No drug interventions Not Available Not Available completed NCT03587714
Prevalence of Hepatitis c Virus Infection Among Rheumatological Patients No drug interventions Not Available Not Available completed NCT00136214
Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects No drug interventions Not Available Not Available completed NCT04314414
Coaching for HCV and HIV No drug interventions health_services_research Not Available completed NCT01108614
Injecting Drug Use Community Intervention Trial No drug interventions prevention 3 unknown_status NCT00047814
Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection No drug interventions treatment 2 completed NCT03313414
HCV Post-Exposure Prophylaxis for Health Care Workers prevention 4 withdrawn NCT01844414
UCLA-Amity Parolee Health Promotion Study No drug interventions health_services_research Not Available completed NCT03242655
HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention No drug interventions treatment Not Available completed NCT01446250
Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1 treatment 3 terminated NCT04741750
Increasing HCV Linkage to Care Among People Who Inject Drugs No drug interventions health_services_research Not Available completed NCT04457050
Effect of Hepatitis C Clearance on Insulin Resistance treatment 4 completed NCT03145623
Retrospective Efficacy and Safety Study With Elbasvir/Grazoprevir in HCV-infected Patients With Chronic Kidney Disease Not Available Not Available completed NCT01410123
Integrated Stepped Care for Unhealthy Alcohol Use in HIV No drug interventions treatment Not Available completed NCT03000023
Anticipated and Perceived Benefits Following Hepatitis C Treatment No drug interventions Not Available Not Available completed NCT04961723
HCV Self-testing in Georgia No drug interventions diagnostic Not Available unknown_status NCT01770223
A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113) treatment 4 withdrawn NCT00882908
A Study of TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment treatment 2 completed NCT04153708
Retrieval of Hepatitis C Patients Lost to Follow-up No drug interventions treatment Not Available unknown_status NCT01074008
A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072 treatment 2 completed NCT00260208
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus prevention 4 terminated NCT05102838
Prospective Cohort Study on Prognosis of Patients With Hepatitis B/C No drug interventions Not Available Not Available not_yet_recruiting NCT02315638
Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034. No drug interventions Not Available Not Available terminated NCT00006643
Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus No drug interventions Not Available Not Available completed NCT00841243
Nutritional Support During Antiviral Therapy for Hepatitis C No drug interventions prevention 4 unknown_status NCT01281423
Safety and Efficacy of ANA598 Administered With Pegylated Interferon and Ribavirin in Genotype-1 Patients With Chronic HCV Infection treatment 2 unknown_status NCT02031133
Long-term Extension to Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Not Available 2 unknown_status NCT00725803
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV treatment 2 completed NCT00768690
A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333 Not Available 1 completed NCT00895102
Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers Not Available 1 completed NCT01193478
A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C treatment 1 completed NCT02397707
Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment treatment 1 completed NCT00213707
Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution. No drug interventions Not Available Not Available unknown_status NCT01463956
Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation treatment 2 completed NCT02402452
Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment treatment 1 completed NCT00623649
Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection No drug interventions treatment 1 completed NCT00890318
A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C Not Available 1 completed NCT01965535
Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection treatment 2 completed NCT00726882
A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 Studies Not Available 2 completed NCT01277627
Influence of Nevirapine on HCV Viral Load Not Available Not Available unknown_status NCT04008927
A Community-based Intervention Among Active Drug Users in Montpellier No drug interventions screening Not Available completed NCT00850044
Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1 treatment 1 completed NCT02707601
Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment treatment 3 completed NCT00696904
Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects other 1 completed NCT04159246
Role OF OCT-A TO Detect Possible Retinal Vascular Complications of Sofosbuvir in Patients With Hepatitis C Not Available Not Available unknown_status NCT01958281
Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency treatment 2 completed NCT00743795
Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection treatment 2 completed NCT01072695
Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection treatment 2 completed NCT03461250
Chronic Hepatitis C in Chronic Hemodialysis Recipients - An Observational Study No drug interventions Not Available Not Available unknown_status NCT03588923
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection No drug interventions treatment 1 completed NCT00893308
Metabolic Viral Host Properties No drug interventions Not Available Not Available completed NCT05534633
APPROACH 2.0: HIV, HCV and Syphilis Testing Through Pharmacies No drug interventions screening Not Available active_not_recruiting NCT04062253
Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid No drug interventions Not Available Not Available completed NCT01987453
Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study treatment 2 completed NCT05992077
Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia treatment Not Available recruiting NCT00401947
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C Infection No drug interventions treatment 2 terminated NCT00978497
Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection treatment 2 completed NCT00909311
Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir treatment 1 completed NCT01121185
Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C prevention 2 terminated NCT03508115
Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents No drug interventions Not Available Not Available completed NCT03379506
Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079) treatment 2 completed NCT04235049
Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE) treatment 4 withdrawn NCT00909636
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet treatment 1 completed NCT00221624
Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients treatment 3 completed NCT00874796
Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection treatment 2 terminated NCT03794258
Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection No drug interventions treatment 2 withdrawn NCT04353986
PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders treatment 3 recruiting NCT04044586
HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST) No drug interventions Not Available Not Available unknown_status NCT03674125
Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection No drug interventions prevention 1 completed NCT01211626
Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) treatment 1 completed NCT00170131
MMF Influence on HCV Viral Evolution After Liver Transplantation No drug interventions Not Available Not Available completed NCT02533427
Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol treatment 1 completed NCT01181427
Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects treatment 1 completed NCT02783976
Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice Not Available Not Available completed NCT04134767
Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE) No drug interventions prevention Not Available completed NCT00931281
Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir treatment 1 completed NCT02716428
A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection treatment 2 completed NCT02593162
A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection treatment 2 completed NCT02478229
Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT) treatment 3 terminated NCT04513899
Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless Adults No drug interventions treatment Not Available completed NCT03111108
Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096) No drug interventions treatment 4 completed NCT01314261
Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects treatment 2 completed NCT01838590
Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection treatment 3 completed NCT02951364
Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea Not Available Not Available completed NCT02442284
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection treatment 3 completed NCT02723084
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection treatment 3 completed NCT02460133
Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment treatment 4 active_not_recruiting NCT02219477
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis treatment 3 completed NCT01741545
Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia treatment 3 completed NCT00947245
Japanese Bridging Study Conducted in the United States Not Available 1 withdrawn NCT00671671
Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus. treatment 1 completed NCT01030432
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin treatment 2 completed NCT02582632
A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults treatment 3 completed NCT00219999
Hepatitis C Virus and the Humoral Immune System No drug interventions Not Available Not Available completed NCT02103699
A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir Not Available Not Available completed NCT01605513
Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease No drug interventions treatment 1 / 2 completed NCT00179413
Study of Long-term Peg Intron vs. Colchicine in Non-responders. prevention 4 completed NCT01134718
TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration treatment 1 completed NCT01836718
Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver Transplantation No drug interventions Not Available Not Available unknown_status NCT02604017
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection treatment 3 completed NCT02446717
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy treatment 2 / 3 completed NCT01391117
TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin treatment 1 terminated NCT02907996
Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in Korea Not Available Not Available completed NCT01040039
Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV No drug interventions Not Available Not Available terminated NCT02068222
A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection treatment 2 completed NCT01022125
TMC435-TiDP16-C121: A Study Comparing 2 Tablet Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Effect of Food on Blood Levels of TMC435 treatment 1 completed NCT00633230
Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C No drug interventions treatment 1 withdrawn NCT02349048
Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection treatment 2 completed NCT02640157
A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection treatment 3 completed NCT00194857
Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin treatment 4 terminated NCT01323257
TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r) treatment 1 completed NCT02592057
Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India Not Available Not Available completed NCT02173574
Two-way Interaction Between Alisporivir and EDP239 treatment 1 completed NCT00956982
PEG-IFN Plus Ribavirin Combination Therapy for Older Patients treatment Not Available unknown_status NCT02773394
Study to Describe the Actual Situation of Hepatitis C Treatment in Brazil No drug interventions Not Available Not Available completed NCT02243280
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection treatment 2 completed NCT01628692
Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus treatment 2 completed NCT01271140
High Dose Insulin Therapy to Improve Liver Function treatment Not Available unknown_status NCT00710801
Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation No drug interventions Not Available Not Available completed NCT01486004
A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen treatment 1 completed NCT01188772
Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients treatment 2 completed NCT06104046
Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis No drug interventions Not Available Not Available not_yet_recruiting NCT02893046
HCV Care Pathway in Ile-de-France No drug interventions Not Available Not Available unknown_status NCT02636595
The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4) treatment 3 completed NCT01097395
Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection treatment 4 completed NCT01063023
Drug Interaction Oral Contraceptive Pill (OCP) Not Available 1 completed NCT02692703
A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2) treatment 3 completed NCT01581203
Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives) treatment 3 completed NCT01598090
Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir treatment 3 completed NCT00678587
Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures treatment 3 terminated NCT00896233
Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED) No drug interventions diagnostic 1 completed NCT02105454
Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin in Participants With Chronic Hepatitis C Who Failed Prior Direct-Acting Antiviral Therapy (MK-5172-048) treatment 2 completed NCT01573351
Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials) treatment 3 completed NCT00503347
Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus treatment 1 completed NCT00382798
Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin treatment 1 / 2 completed NCT01396005
A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123) treatment 1 completed NCT01713283
Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection treatment 2 completed NCT01193361
Ph IIA Study (SOC +/- NS5B) treatment 2 completed NCT02243293
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection treatment 2 / 3 completed NCT01995071
A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV) treatment 2 completed NCT02207088
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease treatment 3 completed NCT03639207
IFNL4 Genotype for Predicting Response to Ledipasvir/Sofosbuvir No drug interventions Not Available Not Available withdrawn NCT02073656
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection treatment 3 completed NCT02265237
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1) treatment 3 completed NCT01629732
Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C treatment 2 withdrawn NCT02707952
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection treatment 3 completed NCT01090700
TMC435-TiDP16-C112 - Interaction Trial With Antidepressants treatment 1 completed NCT00143000
Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3 treatment 4 completed NCT02597270
An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection No drug interventions Not Available Not Available completed NCT01288742
TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and Rosuvastatin treatment 1 completed NCT01124799
TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun Light treatment 1 completed NCT00342641
Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers No drug interventions Not Available Not Available completed NCT00705224
Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562) Not Available Not Available completed NCT00861458
Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State basic_science 1 completed NCT00810758
Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04878691 No drug interventions treatment 1 completed NCT01046058
TMC435-TiDP16-C113: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of TMC435 treatment 1 completed NCT01381835
TMC435-TiDP16-C126 - Trial to Investigate the Effect of Severe Renal Impairment on the Pharmacokinetics and Safety of TMC435 treatment 1 completed NCT01458535
A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV) treatment 2 completed NCT01205139
TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir treatment 1 completed NCT00894257
Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population No drug interventions Not Available Not Available completed NCT00819026
Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors No drug interventions Not Available Not Available completed NCT02581020
The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects No drug interventions Not Available Not Available completed NCT04038320
Simplified Antiviral Treatment Strategy for Hepatitis C in Ukraine Not Available Not Available completed NCT01006031
Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4 treatment 2 / 3 completed NCT01241773
TMC435-TiDP16-C123 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents Efavirenz and Raltegravir treatment 1 completed NCT02058173
"Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study" treatment 4 completed NCT02170727
A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1 treatment 3 completed NCT01170962
Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment treatment 2 completed NCT01125189
Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients treatment 2 completed NCT02002767
Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment treatment 1 completed NCT01257204
Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection treatment 2 completed NCT02023112
Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection treatment 3 completed NCT01195181
Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice. treatment 4 completed NCT01479881
A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus treatment 1 completed NCT02092350
Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052) treatment 2 / 3 completed NCT05756738
Acceptance and Feasibility of Hepatitis c Screening Strategies in Social Insertion Centers No drug interventions screening Not Available recruiting NCT00496912
Management of Hepatitis C in HIV-Infected and Uninfected IDUs treatment 4 completed NCT03144635
A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir treatment 4 completed NCT03356405
Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV No drug interventions Not Available Not Available active_not_recruiting NCT03682549
Oral Microbiome of Patients With Hepatitis C Virus Infection No drug interventions Not Available Not Available completed NCT06623058
Accupower ® HCV Performance Evaluation Quant Kit Bioneer Existation™FA 96/384 No drug interventions Not Available Not Available not_yet_recruiting NCT06605573
Lay User Evaluation of the Panbio™ HCV Self-Test No drug interventions diagnostic Not Available not_yet_recruiting NCT05657106
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk No drug interventions prevention Not Available active_not_recruiting NCT02476617
Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults treatment 3 completed NCT05968573
Persuasive Health Communication Intervention for HIV/HCV No drug interventions health_services_research Not Available recruiting NCT01464827
ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients treatment 2 completed NCT01750515
Acupuncture as an Adjunctive Treatment for Hepatitis C Patients No drug interventions Not Available Not Available unknown_status NCT00651027
Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554 treatment 1 completed NCT02493855
Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults treatment 2 completed NCT05320835
A Setting Focus Overdose Prevention Intervention No drug interventions health_services_research Not Available recruiting NCT06483451
Facilitated Telemedicine in the Catholic Health System No drug interventions Not Available Not Available not_yet_recruiting NCT06604182
Innovate, Involve, Inspire No drug interventions treatment Not Available not_yet_recruiting NCT04286347
HCV, HBV, HIV Testing During Consultation With Anesthesiologist No drug interventions diagnostic Not Available terminated NCT00823745
Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects basic_science 1 completed NCT03981445
Integrated HIV Prevention and HCV Care for PWID No drug interventions treatment Not Available active_not_recruiting NCT05616598
Effect of New Oral Treatment for Hepatitis C Virus on Seminal Parameters basic_science 2 / 3 completed NCT03389061
Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet other 4 withdrawn NCT05854511
Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in HCV-infected Children treatment 3 recruiting NCT03221309
Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior No drug interventions Not Available Not Available active_not_recruiting NCT05942937
National Prisons Hepatitis Education Project: Research Evaluation No drug interventions other Not Available recruiting NCT05653232
Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients No drug interventions treatment Not Available recruiting NCT05597800
Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome treatment 2 not_yet_recruiting NCT03288636
Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China treatment 1 completed NCT06508996
Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System No drug interventions Not Available Not Available completed NCT06316739
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City No drug interventions prevention Not Available not_yet_recruiting NCT04378439
Appalachian Partnership to Reduce Disparities (Aim 2) No drug interventions prevention Not Available recruiting NCT04971330
Access Anti-HCV Assay European Union (EU) Clinical Trial Protocol No drug interventions Not Available Not Available completed NCT02247401
Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt treatment 3 completed NCT03069001
Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Treatment of HCV treatment 4 completed NCT05781568
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available recruiting NCT02452814
Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection No drug interventions Not Available Not Available completed NCT03362814
Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects. treatment 2 / 3 completed NCT03820102
Impact of Metabolic Changes and Vitamin D Status on Virological Response in Patients With HCV Infection Treated by DAAs No drug interventions Not Available Not Available unknown_status NCT05454579
The South-East Asian Transgender Health Cohort No drug interventions Not Available Not Available recruiting NCT00489385
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals treatment 1 completed NCT05181332
Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis No drug interventions Not Available Not Available recruiting NCT05276700
Alpha -1- Microglobulin (α1M) as an Early Biomarker in Renal Extrahepatic Manifestations of HCV-infection No drug interventions Not Available Not Available unknown_status NCT03105349
A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A treatment 4 withdrawn NCT06579313
Current Situation of Health Care in Women With HBV or HCV Infection No drug interventions Not Available Not Available not_yet_recruiting NCT02658786
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease No drug interventions Not Available Not Available withdrawn NCT06528626
Tools to Identify People at Risk or Already Infected With HIV and HCV No drug interventions screening Not Available recruiting NCT03721627
Chronic Hepatitis C Treatment in Egyptian Children With Gaucher Disease. treatment 4 unknown_status NCT00752544
TMC435350-TiDP16-C109: A Safety Study for TMC435350 in an Oral Solution Containing Either 100, 200 or 400 mg Equivalent of TMC435350 or Placebo in Healthy Japanese Male Volunteers treatment 1 completed NCT04631640
Prognostic Model of HCV-related Disease Progression After DAAs No drug interventions Not Available Not Available not_yet_recruiting NCT03572140
Safety of Sofosbuvir ,Daclatasvir in HCV Patients and RAVS in Resistent and Relapsed Cases No drug interventions Not Available Not Available unknown_status NCT05794646
Community Intervention to Eliminate HCV Among People Who Use Drugs. No drug interventions treatment Not Available recruiting NCT01766115
Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers prevention 4 withdrawn NCT02125500
Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection treatment 2 completed NCT01953458
Therapeutic Option for Hepatitis B and C: a French Cohort No drug interventions Not Available Not Available active_not_recruiting NCT05751889
Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSM No drug interventions prevention Not Available recruiting NCT04690972
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". No drug interventions Not Available Not Available not_yet_recruiting NCT04470271
Re-linkage to Care of Patients With Hepatitis C No drug interventions Not Available Not Available unknown_status NCT03566966
Autoantibodies and Direct-acting Antivirals No drug interventions Not Available Not Available completed NCT01288417
Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir treatment 1 completed NCT01470690
Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO) other 1 completed NCT00919490
A Study of Single Dose of ABT-333 in Healthy Male Adults treatment 1 completed NCT04903626
Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB) treatment 3 completed NCT03212521
Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1 treatment 3 completed NCT03235349
Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection treatment 3 completed NCT01616524
Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 treatment 3 completed NCT01754974
Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C treatment 3 completed NCT04189627
A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation No drug interventions Not Available Not Available completed NCT03067129
A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection treatment 2 / 3 completed NCT03089944
A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis treatment 3 completed NCT02966795
A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection treatment 3 completed NCT03222583
A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection treatment 3 completed NCT04214028
A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus No drug interventions Not Available Not Available recruiting NCT03341871
Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6 No drug interventions Not Available Not Available completed NCT04352309
Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis No drug interventions Not Available Not Available completed NCT02517515
ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection treatment 3 completed NCT02609659
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection treatment 3 completed NCT02487199
Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease treatment 3 completed NCT03201718
A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs No drug interventions Not Available Not Available completed NCT03219216
A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection treatment 3 completed NCT03069365
A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment treatment 3 completed NCT04577482
Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response No drug interventions Not Available Not Available completed NCT04366973
A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers No drug interventions Not Available Not Available completed NCT01447394
Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C treatment 3 withdrawn